These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 19713424

  • 21. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
    Karadağ C, Yoldemir T.
    J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
    [Abstract] [Full Text] [Related]

  • 22. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A, Tasci I, Tapan S, Basaran Y, Aydogan U, Meric C, Sonmez A, Aydogdu S, Akbulut H, Taslipinar A, Uckaya G, Azal O.
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [Abstract] [Full Text] [Related]

  • 23. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [Abstract] [Full Text] [Related]

  • 24. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.
    Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
    [Abstract] [Full Text] [Related]

  • 25. Association of serum pigment epithelium-derived factor with high-sensitivity C-reactive protein in women with polycystic ovary syndrome.
    Cheng Q, Xia W, Yang S, Ye P, Mei M, Song Y, Luo M, Li Q.
    J Endocrinol Invest; 2013 Sep; 36(8):632-5. PubMed ID: 24105071
    [Abstract] [Full Text] [Related]

  • 26. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
    Moradi S, Mollabashi M, Kerman SR.
    Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
    [Abstract] [Full Text] [Related]

  • 27. Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome.
    Hu W, Qiao J, Yang Y, Wang L, Li R.
    Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):53-6. PubMed ID: 21530057
    [Abstract] [Full Text] [Related]

  • 28. Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: a case-control study of women from Bahraini medical clinics.
    Kalyan S, Goshtesabi A, Sarray S, Joannou A, Almawi WY.
    BMJ Open; 2018 Oct 27; 8(10):e021860. PubMed ID: 30368447
    [Abstract] [Full Text] [Related]

  • 29. Association between red blood cell distribution width and polycystic ovary syndrome.
    Yilmaz Ö, Mehmet C, Kelekci S, Temur M.
    Endocr Res; 2015 Oct 27; 40(4):181-7. PubMed ID: 25531764
    [Abstract] [Full Text] [Related]

  • 30. Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.
    Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Müller B.
    J Clin Endocrinol Metab; 2005 Nov 27; 90(11):6014-21. PubMed ID: 16105965
    [Abstract] [Full Text] [Related]

  • 31. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M, Aydemir M, Tuzcu A.
    Fertil Steril; 2007 Jun 27; 87(6):1363-8. PubMed ID: 17362944
    [Abstract] [Full Text] [Related]

  • 32. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.
    Cakal E, Ustun Y, Engin-Ustun Y, Ozkaya M, Kilinç M.
    Gynecol Endocrinol; 2011 Jul 27; 27(7):491-5. PubMed ID: 20626239
    [Abstract] [Full Text] [Related]

  • 33. Intrinsic factors rather than vitamin D deficiency are related to insulin resistance in lean women with polycystic ovary syndrome.
    Sahin S, Eroglu M, Selcuk S, Turkgeldi L, Kozali S, Davutoglu S, Muhcu M.
    Eur Rev Med Pharmacol Sci; 2014 Oct 27; 18(19):2851-6. PubMed ID: 25339479
    [Abstract] [Full Text] [Related]

  • 34. White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.
    Papalou O, Livadas S, Karachalios A, Tolia N, Kokkoris P, Tripolitakis K, Diamanti-Kandarakis E.
    Hormones (Athens); 2015 Oct 27; 14(1):91-100. PubMed ID: 25553762
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome.
    Rashad NM, El-Shal AS, Abdelaziz AM.
    J Reprod Immunol; 2013 Apr 27; 97(2):232-9. PubMed ID: 23218400
    [Abstract] [Full Text] [Related]

  • 38. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS).
    Barrea L, Arnone A, Annunziata G, Muscogiuri G, Laudisio D, Salzano C, Pugliese G, Colao A, Savastano S.
    Nutrients; 2019 Sep 23; 11(10):. PubMed ID: 31547562
    [Abstract] [Full Text] [Related]

  • 39. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA, Morales AJ, Yen SS.
    J Clin Endocrinol Metab; 1997 Jun 23; 82(6):1692-6. PubMed ID: 9177365
    [Abstract] [Full Text] [Related]

  • 40. Fractalkine: an inflammatory chemokine elevated in subjects with polycystic ovary syndrome.
    Demi R İ, Guler A, Alarslan P, Isil AM, Ucman O, Aslanipour B, Calan M.
    Endocrine; 2019 Jul 23; 65(1):175-183. PubMed ID: 31154608
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.